THE IMPACT OF INNOVATION ON THE PROFITABILITY OF SLOVAK PHARMACEUTICAL COMPANIES

被引:3
|
作者
Lehenchuk, Serhii [1 ]
Tumpach, Milos [2 ,3 ]
Vyhivska, Iryna [1 ]
Makarovych, Viktoriia [4 ]
Laichuk, Svitlana [1 ]
机构
[1] Zhytomyr Polytech State Univ, Zhytomyr, Ukraine
[2] Univ Econ Bratislava, Bratislava, Slovakia
[3] Brno Univ Technol, Brno, Czech Republic
[4] Ferenc Rakoczi II Transcarpathian Hungarian Inst, Berehove, Czech Republic
关键词
financial performance; pharmaceutical companies; profitability; research and development; RESEARCH-AND-DEVELOPMENT; FINANCIAL PERFORMANCE EVIDENCE; GROWTH;
D O I
10.21272/mmi.2022.2-25
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
In conditions of the knowledge economy and innovations, research and development activities are among the most important factors affecting companies' financial performance. This study aims to investigate the impact of research and development activities on the profitability of Slovak pharmaceutical companies. The panel dataset consists of 37 sample pharmaceutical companies for 2015-2019. Panel data regression analysis was used as the main research method of the study. Profitability was measured with the return on assets indicator, chosen as the dependent variable. The independent variables are leverage, research and development intensity, research and development intensity squared, size, and high-tech dummy. The empirical analysis includes descriptive statistics, normality test, autocorrelation test, and panel regression models (random effect model) followed by F-statistics test, Hausman test, and Breusch-Pagan test. The hypothesis that there is a significant positive impact of research and development activities on the profitability of knowledge-intensive enterprises has been partly confirmed. Only the research and development intensity squared has a significant positive impact on the profitability of Slovak pharmaceutical companies at a 1% level. On the contrary, the research and development intensity has a significant negative relation. According to the analysis results, control variables (leverage, size, and high-tech dummy) have no significant influence on profitability. The existence of an inverted-U relationship between research and development activities and the profitability of Slovak pharmaceutical companies has been established. Investing in innovations of Slovak pharmaceutical companies has a positive effect on profitability only from a certain amount and has an upper limit on the amount of profitable investment. Thus, to formulate recommendations on the adjustment of investment policy in research and development activities, it is necessary to conduct future research to determine the entry points and exit points from the area of best profitability on inverted-U function.
引用
收藏
页码:284 / 296
页数:13
相关论文
共 50 条
  • [41] The Impact of Innovations on the Competitiveness Of Companies in the Food Industry in the Slovak Republic
    Majernik, Milan
    Majernik, Stefan
    Babelova, Janka
    EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT THROUGH VISION 2020, 2019, : 8200 - 8208
  • [42] Impact of the Business Environment on Development of Innovation in Slovak Republic
    Fabova, L'udmila
    Janakova, Hana
    INTERNATIONAL SCIENTIFIC CONFERENCE: BUSINESS ECONOMICS AND MANAGEMENT (BEM2015), 2015, 34 : 66 - 72
  • [43] The Necessity of Obtaining Information Through Marketing Research in The Field of Pharmaceutical Companies on The Slovak Market
    Masarova, Gabriela
    Stefanikova, L'ubica
    Rypakova, Martina
    2ND GLOBAL CONFERENCE ON BUSINESS, ECONOMICS, MANAGEMENT AND TOURISM, 2015, 23 : 1480 - 1484
  • [44] The Impact of Working Capital Management on Profitability of Pharmaceutical Industry in India
    Pandey, N. S.
    Sugumari, G.
    Azhagaiah, R.
    PACIFIC BUSINESS REVIEW INTERNATIONAL, 2016, 9 (06): : 92 - 106
  • [45] Profitability of Stock Companies
    不详
    ARCHIV FUR SOZIALWISSENSCHAFT UND SOZIALPOLITIK, 1909, 29 (01): : 272 - 272
  • [46] THE IMPACT OF CORPORATE SOCIAL RESPONSIBILITY ON FIRM PERFORMANCE WITH MEDIATING EFFECT OF INNOVATION; EVIDENCE FROM PHARMACEUTICAL COMPANIES OF THAILAND
    Park, Tiwa
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 540 - 545
  • [47] Reintegration of slovak researchers returning to slovak companies
    Šramová, Veronika
    Závodská, Anna
    Lendel, Viliam
    Lecture Notes in Business Information Processing, 2015, 224 : 353 - 364
  • [48] The impact of research and development and marketing costs on the profitability of pharmaceutical companies of Tehran Stock Exchange using panel data 2001-2013
    Bayazidi, Yahya
    Rad, Enayatollah Homaie
    Mojahedian, Mehdi
    Toroski, Mehdi
    Nabizadeh, Azita
    Farahmand, Parna
    Nasiri, Banafshe Felezi
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2016, 10 (04) : 467 - 476
  • [49] Innovation management of Japanese pharmaceutical companies: the case of an antibiotic developed by Takeda
    Hara, T
    INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 2005, 30 (3-4) : 351 - 364
  • [50] Linkage between innovation and intellectual property rights in Chinese pharmaceutical companies
    Yuanliang, Zhao
    Jizhong, Zholi
    ISMOT'07: Proceedings of the Fifth International Symposium on Management of Technology, Vols 1 and 2: MANAGING TOTAL INNOVATION AND OPEN INNOVATION IN THE 21ST CENTURY, 2007, : 649 - 653